MX2017004505A - Composicion de preparacion externa que contiene s-flurbiprofeno. - Google Patents

Composicion de preparacion externa que contiene s-flurbiprofeno.

Info

Publication number
MX2017004505A
MX2017004505A MX2017004505A MX2017004505A MX2017004505A MX 2017004505 A MX2017004505 A MX 2017004505A MX 2017004505 A MX2017004505 A MX 2017004505A MX 2017004505 A MX2017004505 A MX 2017004505A MX 2017004505 A MX2017004505 A MX 2017004505A
Authority
MX
Mexico
Prior art keywords
flurbiprofen
external preparation
preparation composition
composition containing
ester
Prior art date
Application number
MX2017004505A
Other languages
English (en)
Other versions
MX371533B (es
Inventor
UCHIKAWA Yasumasa
Sato Takayuki
MATSUKI Kota
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of MX2017004505A publication Critical patent/MX2017004505A/es
Publication of MX371533B publication Critical patent/MX371533B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Abstract

Un objetivo de la presente invención es el de proporcionar una composición para aplicación externa que contiene S-flurbiprofeno y aceite de menta como potenciador de penetración en la piel, en la cual una disminución dependiente del tiempo en el contenido de S-flurbiprofeno se suprime para mejorar la estabilidad de almacenamiento de S-flurbiprofeno; para lograr este objetivo, al menos un miembro seleccionado del grupo que consiste en un éster que tiene dos ácidos grasos de cadena media enlazados con propilenglicol y un éster que tiene tres ácidos grasos de cadena media enlazados con glicerina se incorpora en una composición para aplicación externa que contiene S-flurbiprofeno y aceite de menta como potenciador de penetración en la piel.
MX2017004505A 2014-10-07 2015-09-15 Composicion de preparacion externa que contiene s-flurbiprofeno. MX371533B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014206781 2014-10-07
PCT/JP2015/076109 WO2016056356A1 (ja) 2014-10-07 2015-09-15 Ｓ－フルルビプロフェンを含有する外用剤組成物

Publications (2)

Publication Number Publication Date
MX2017004505A true MX2017004505A (es) 2017-06-26
MX371533B MX371533B (es) 2020-01-30

Family

ID=55652977

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017004505A MX371533B (es) 2014-10-07 2015-09-15 Composicion de preparacion externa que contiene s-flurbiprofeno.

Country Status (14)

Country Link
EP (1) EP3205341A4 (es)
JP (2) JP6023358B2 (es)
KR (1) KR20170063700A (es)
CN (1) CN107148269B (es)
AU (1) AU2015329319B2 (es)
BR (1) BR112017005759A2 (es)
CA (1) CA2962034A1 (es)
MX (1) MX371533B (es)
MY (1) MY187120A (es)
PH (1) PH12017500528B1 (es)
RU (1) RU2715907C2 (es)
SG (1) SG11201702334SA (es)
TW (1) TWI717323B (es)
WO (1) WO2016056356A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7049258B2 (ja) * 2016-10-12 2022-04-06 帝國製薬株式会社 水性貼付剤
JP6877737B2 (ja) * 2017-03-31 2021-05-26 三笠製薬株式会社 フルルビプロフェン含有含水系貼付剤
WO2020032271A1 (ja) 2018-08-10 2020-02-13 国立大学法人東北大学 多価アルコールエステル化合物の製造方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5829706A (ja) * 1981-08-14 1983-02-22 Toko Yakuhin Kogyo Kk 消炎鎮痛外用剤
JPH06199701A (ja) * 1992-12-29 1994-07-19 Lion Corp 外用消炎鎮痛剤
JP3402682B2 (ja) * 1993-09-08 2003-05-06 サンスター株式会社 歯磨組成物
JP3782834B2 (ja) * 1994-10-26 2006-06-07 株式会社トクホン 鎮痛抗炎症貼付剤
JP2002225883A (ja) * 2001-02-01 2002-08-14 Saitama Daiichi Seiyaku Kk 貼付剤用包装袋
JP4818575B2 (ja) * 2003-06-30 2011-11-16 ライオン株式会社 外用貼付剤及び放射線照射外用貼付剤の変色防止方法
JP2007502823A (ja) * 2003-08-15 2007-02-15 キューエルティー・ユーエスエイ・インコーポレーテッド 接着性および生体侵食性の経粘膜薬物送達システム
US7442399B2 (en) * 2004-06-25 2008-10-28 Kraft Foods Holdings, Inc. Aroma-producing compositions for foods
JP4762565B2 (ja) * 2005-02-08 2011-08-31 久光製薬株式会社 包装袋
JP2009204389A (ja) * 2008-02-27 2009-09-10 Toppan Printing Co Ltd 離型フィルムおよび薬品移行性の評価方法
RU2011141091A (ru) * 2009-03-11 2013-04-20 Кова Ко., Лтд. Наружный препарат, содержащий обезболивающее/ противовоспалительное средство
CN102341123A (zh) * 2009-03-11 2012-02-01 兴和株式会社 含有镇痛-抗炎症剂的外用剂
CN102341122A (zh) * 2009-03-11 2012-02-01 兴和株式会社 含有镇痛-抗炎症剂的外用剂
GB201010954D0 (en) * 2010-06-29 2010-08-11 Edko Pazarlama Tanitim Ticaret Compositions
JP2012219055A (ja) * 2011-04-07 2012-11-12 Nitto Denko Corp 貼付製剤およびその包装体
JP2013066644A (ja) * 2011-09-26 2013-04-18 Toppan Printing Co Ltd 消炎鎮痛成分低吸着包材
GB201216893D0 (en) * 2012-09-21 2012-11-07 Aesica Pharmaceuticals Ltd Drug substance preparations, pharmaceutical compositions and dosage forms comprising s-(+)-flurbiprofen

Also Published As

Publication number Publication date
EP3205341A1 (en) 2017-08-16
JP6683443B2 (ja) 2020-04-22
MY187120A (en) 2021-09-02
JPWO2016056356A1 (ja) 2017-04-27
JP6023358B2 (ja) 2016-11-09
CA2962034A1 (en) 2016-04-14
KR20170063700A (ko) 2017-06-08
AU2015329319B2 (en) 2018-12-13
RU2017115933A (ru) 2018-11-13
TWI717323B (zh) 2021-02-01
SG11201702334SA (en) 2017-05-30
JP2016073623A (ja) 2016-05-12
CN107148269A (zh) 2017-09-08
PH12017500528A1 (en) 2017-08-07
MX371533B (es) 2020-01-30
EP3205341A4 (en) 2018-05-30
PH12017500528B1 (en) 2017-08-07
WO2016056356A1 (ja) 2016-04-14
RU2715907C2 (ru) 2020-03-04
RU2017115933A3 (es) 2019-03-06
BR112017005759A2 (pt) 2017-12-12
CN107148269B (zh) 2020-03-31
AU2015329319A1 (en) 2017-04-20
TW201625228A (zh) 2016-07-16

Similar Documents

Publication Publication Date Title
CO7121328A2 (es) Composiciones de ester de ácido graso omega -3
MX366561B (es) Composicion que contiene minoxidil para el crecimiento del pelo.
BR112017022209A2 (pt) composição aquosa que compreende éster de ácido omega- aminocarboxílico e álcool graxo e seu uso
WO2014057362A3 (en) Omega -3 compositions
EA201590491A1 (ru) Иммуногенная композиция
CL2015002433A1 (es) Imidazopiridazinas sustituidas
BR112019024623A2 (pt) Uso de uma esterase para aumentar teor de éster de etila em meios de fermentação
DK3149105T3 (da) Anvendelse af syntetiske syresammensætninger som alternativer til konventionelle syrer i olie- og gasindustrien
MX2017006148A (es) Composiciones para el cuidado personal con dos fases beneficas.
SA515361092B1 (ar) تركيبات راسكادوتريل الدهنية
PH12017500528A1 (en) External preparation composition containing s-flurbiprofen
MX370990B (es) Ésteres de ácidos oligo-hidroxicarboxílicos y uso de los mismos.
DOP2016000007A (es) Pirazolpiridinas sustituidas
WO2013143935A3 (en) Dry shampoo composition
MY183624A (en) Transparent sunscreen compositions and use thereof
MX2021001790A (es) Composiciones solidas de trigliceridos y usos de estas.
EP3423537A4 (en) FATTY ACID AND RESIN ACID COMPOSITIONS FOR USE AS SOFTENERS IN ADHESIVE FORMULATIONS AND RELATED METHODS FOR USE
WO2014169003A3 (en) Multi-functional composition for cosmetic formulations
WO2014068282A3 (en) Composition
MY181719A (en) Fragrance and flavor compositions comprising neopentyl glycol diacetate
WO2014096165A3 (en) Gas-filled microvesicles
CL2012003250A1 (es) Uso de un galactolipido en combinacion con acido ascorbico y/o un derivado del mismo que sirve para proteger una composicion contra la oxidacion; metodo para la preparacion de la composicion, composicion; y producto.
BR112016028561A8 (pt) composição e forma de dosagem compreendendo um óleo marinho que compreende ácidos graxos, e, uso das mesmas
WO2013167866A3 (en) Composition
AR106196A1 (es) Compuestos de antioxidantes estables bajo almacenamiento que contienen ácido ascórbico

Legal Events

Date Code Title Description
FG Grant or registration